by Patrice D. Cani
Dysosmobacter welbionis is a typical inhabitant of the human gut. New findings suggest it could be a potential next-generation beneficial bacterium for tackling specific cardiometabolic disorders linked to obesity and type 2 diabetes.
by Patrice D. Cani
Enteric neurons have recently emerged as a new target in the management of type 2 diabetes. The findings in mice and humans identify new intestinal bioactive compounds released after prebiotic administration, with potential for improving glucose metabolism.
Increasing evidence suggests that imbalanced gut microbiota may play a role in insulin resistance in Type 2 Diabetes patients and exercise has shown to have positive effects on the gut microbiome and metabolism.
by Patrice D. Cani
Individuals with obesity and type 2 diabetes have shown an altered gut microbiome composition. A new study has discovered tissue bacterial signatures linked to type 2 diabetes.
by Andreu Prados
Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.
by GMFH Editing Team
Ruling out the specific contribution of obesity and type 2 diabetes in gut microbiome variation is a challenge. Louise Thingholm and colleagues have found that while obesity is linked to gut microbiome variation, gut microbiome associations with type 2 diabetes are modest.
by Andreu Prados
A new randomized clinical trial has found that promotion of a select group of gut bacteria by a diet high in diverse fibers may lead to better blood glucose and lipid control and greater weight loss in people with T2DM.
by Andreu Prados
A new multicentre, randomised controlled clinical trial, led by Prof. Weiqing Wang from the Shanghai National Research Centre for Endocrine and Metabolic Diseases at the Shanghai Jiaotong University School of Medicine in Shanghai (China), has found that gut microbiota may help predict which patients with T2D respond to treatment with Acarbose.
by GMFH Editing Team
Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).
by Andreu Prados
A new randomized, placebo-controlled, double-blind study has found both clinical and mechanistic evidence that metformin’s improved blood glucose control is achieved through modulation of the gut microbiota.
